These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 21084696)

  • 1. Hypertrophic phenotype in cardiac cell assemblies solely by structural cues and ensuing self-organization.
    Chung CY; Bien H; Sobie EA; Dasari V; McKinnon D; Rosati B; Entcheva E
    FASEB J; 2011 Mar; 25(3):851-62. PubMed ID: 21084696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertrophic Effects of Nebivolol on Neonatal Cardiomyocyte Hypertrophy Models.
    Ozakca I
    J Cardiovasc Pharmacol; 2019 Mar; 73(3):155-164. PubMed ID: 30601193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Culture on electrospun polyurethane scaffolds decreases atrial natriuretic peptide expression by cardiomyocytes in vitro.
    Rockwood DN; Akins RE; Parrag IC; Woodhouse KA; Rabolt JF
    Biomaterials; 2008 Dec; 29(36):4783-91. PubMed ID: 18823659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-22 downregulation by atorvastatin in a mouse model of cardiac hypertrophy: a new mechanism for antihypertrophic intervention.
    Tu Y; Wan L; Bu L; Zhao D; Dong D; Huang T; Cheng Z; Shen B
    Cell Physiol Biochem; 2013; 31(6):997-1008. PubMed ID: 23860036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pressure-independent cardiac hypertrophy in mice with cardiomyocyte-restricted inactivation of the atrial natriuretic peptide receptor guanylyl cyclase-A.
    Holtwick R; van Eickels M; Skryabin BV; Baba HA; Bubikat A; Begrow F; Schneider MD; Garbers DL; Kuhn M
    J Clin Invest; 2003 May; 111(9):1399-407. PubMed ID: 12727932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B-type natriuretic peptide prevents acute hypertrophic responses in the diabetic rat heart: importance of cyclic GMP.
    Rosenkranz AC; Hood SG; Woods RL; Dusting GJ; Ritchie RH
    Diabetes; 2003 Sep; 52(9):2389-95. PubMed ID: 12941780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporal characteristics of cardiomyocyte hypertrophy in the spontaneously hypertensive rat.
    Bell D; Kelso EJ; Argent CC; Lee GR; Allen AR; McDermott BJ
    Cardiovasc Pathol; 2004; 13(2):71-8. PubMed ID: 15033155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel insights into the mechanisms mediating the local antihypertrophic effects of cardiac atrial natriuretic peptide: role of cGMP-dependent protein kinase and RGS2.
    Klaiber M; Kruse M; Völker K; Schröter J; Feil R; Freichel M; Gerling A; Feil S; Dietrich A; Londoño JE; Baba HA; Abramowitz J; Birnbaumer L; Penninger JM; Pongs O; Kuhn M
    Basic Res Cardiol; 2010 Sep; 105(5):583-95. PubMed ID: 20352235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering an in vitro organotypic model for studying cardiac hypertrophy.
    Jain A; Hasan J; Desingu PA; Sundaresan NR; Chatterjee K
    Colloids Surf B Biointerfaces; 2018 May; 165():355-362. PubMed ID: 29518684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular physiology of rat cardiac myocytes in cardiac fibrosis: in vitro simulation using the cardiac myocyte/cardiac non-myocyte co-culture system.
    Ikeda K; Tojo K; Udagawa T; Otsubo C; Ishikawa M; Tokudome G; Hosoya T; Tajima N; Nakao K; Kawamura M
    Hypertens Res; 2008 Apr; 31(4):693-706. PubMed ID: 18633182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting Peroxisome Proliferator Activated Receptor α (PPAR α) for the Prevention of Mitochondrial Impairment and Hypertrophy in Cardiomyocytes.
    Kar D; Bandyopadhyay A
    Cell Physiol Biochem; 2018; 49(1):245-259. PubMed ID: 30138942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Qiliqiangxin Attenuates Phenylephrine-Induced Cardiac Hypertrophy through Downregulation of MiR-199a-5p.
    Zhang H; Li S; Zhou Q; Sun Q; Shen S; Zhou Y; Bei Y; Li X
    Cell Physiol Biochem; 2016; 38(5):1743-51. PubMed ID: 27161004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular localization of integrin isoforms in phenylephrine-induced hypertrophic cardiac myocytes.
    Kim DJ; Park SH; Lim CS; Chun JS; Kim JK; Song WK
    Cell Biochem Funct; 2003 Mar; 21(1):41-8. PubMed ID: 12579520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mixed-lineage kinase 1-3 signalling pathway regulates stress response in cardiac myocytes via GATA-4 and AP-1 transcription factors.
    Ola A; Kerkelä R; Tokola H; Pikkarainen S; Skoumal R; Vuolteenaho O; Ruskoaho H
    Br J Pharmacol; 2010 Feb; 159(3):717-25. PubMed ID: 20067472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simplified protocol for culture of murine neonatal cardiomyocytes on nanoscale keratin coated surfaces.
    Jain A; Ravi V; Muhamed J; Chatterjee K; Sundaresan NR
    Int J Cardiol; 2017 Apr; 232():160-170. PubMed ID: 28096043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3,3'-Diindolylmethane attenuates cardiac H9c2 cell hypertrophy through 5'-adenosine monophosphate-activated protein kinase-α.
    Zong J; Wu QQ; Zhou H; Zhang JY; Yuan Y; Bian ZY; Deng W; Dai J; Li FF; Xu M; Fang Y; Tang QZ
    Mol Med Rep; 2015 Jul; 12(1):1247-52. PubMed ID: 25816057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of ventricular myocytes and nonmyocytes interaction during cardiocyte hypertrophy: evidence for endothelin-1 as a paracrine hypertrophic factor from cardiac nonmyocytes.
    Harada M; Itoh H; Nakagawa O; Ogawa Y; Miyamoto Y; Kuwahara K; Ogawa E; Igaki T; Yamashita J; Masuda I; Yoshimasa T; Tanaka I; Saito Y; Nakao K
    Circulation; 1997 Nov; 96(10):3737-44. PubMed ID: 9396478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The orphan receptor NOR1 participates in isoprenaline-induced cardiac hypertrophy by regulating PARP-1.
    Feng XJ; Gao H; Gao S; Li Z; Li H; Lu J; Wang JJ; Huang XY; Liu M; Zou J; Ye JT; Liu PQ
    Br J Pharmacol; 2015 Jun; 172(11):2852-63. PubMed ID: 25625556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polydatin attenuates cardiac hypertrophy through modulation of cardiac Ca2+ handling and calcineurin-NFAT signaling pathway.
    Ding W; Dong M; Deng J; Yan D; Liu Y; Xu T; Liu J
    Am J Physiol Heart Circ Physiol; 2014 Sep; 307(5):H792-802. PubMed ID: 25015961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small heterodimer partner blocks cardiac hypertrophy by interfering with GATA6 signaling.
    Nam YS; Kim Y; Joung H; Kwon DH; Choe N; Min HK; Kim YS; Kim HS; Kim DK; Cho YK; Kim YH; Nam KI; Choi HC; Park DH; Suk K; Lee IK; Ahn Y; Lee CH; Choi HS; Eom GH; Kook H
    Circ Res; 2014 Aug; 115(5):493-503. PubMed ID: 25015078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.